Renishaw plc

Renishaw plc

Renishaw plc is a British engineering and scientific technology company, globally renowned for its pioneering work in the fields of precision measurement, spectroscopy, and manufacturing process control. Founded in 1973 by Sir David McMurtry and John Deer, the company is headquartered in Wotton-under-Edge, Gloucestershire, within the United Kingdom. It is a constituent of the FTSE 250 Index and operates on a global scale, providing advanced metrology and healthcare technologies to a wide range of industries, from aerospace to neurological surgery.

History

The company's origins trace back to 1973 when engineers Sir David McMurtry and John Deer developed a novel touch-trigger probe for measuring fuel pipes for the Rolls-Royce Olympus engine used in the Concorde aircraft. This invention, created in a garden shed in Wotton-under-Edge, solved a critical production challenge and formed the foundation of the business. Throughout the 1980s and 1990s, Renishaw expanded its metrology portfolio, launching innovative products like the Renishaw PH10 motorised indexable head and pioneering the use of interferometry and laser calibration in machine tool applications. A significant milestone was its initial public offering on the London Stock Exchange in 1984. The company later diversified into the healthcare sector, notably through its 2007 acquisition of Neuromed, which provided the basis for its neurosurgical product line.

Products and services

Renishaw's core offerings are divided into two main segments: metrology and healthcare. Its metrology portfolio includes high-precision coordinate measuring machine (CMM) probes, machine tool probing systems for applications on CNC machining centres, and advanced additive manufacturing (metal 3D printing) systems used by companies like Airbus and General Electric. The company is also a world leader in Raman spectroscopy systems for materials analysis, utilized in pharmaceutical development and academic research at institutions like the University of Cambridge. In healthcare, its products include stereotactic neurosurgery systems, such as the Renishaw neuromate, and dental CAD/CAM scanners used for designing dental restorations, competing with firms like Dentsply Sirona.

Operations

Renishaw operates a globally integrated business with major research, development, and manufacturing facilities in the United Kingdom, including its primary sites in Wotton-under-Edge and Stone, Staffordshire. It maintains a direct sales and technical support presence in over 36 countries, with key subsidiaries in the United States, Germany, Japan, China, and India. This extensive network allows it to serve a diverse international customer base spanning the aerospace, automotive, semiconductor, and scientific research sectors. The company's operations are supported by significant investment in research and development, often conducted in collaboration with leading universities and research bodies such as the University of Oxford and the National Physical Laboratory (United Kingdom).

Corporate affairs

Renishaw has a distinctive corporate structure, having been led for decades by its founders, with Sir David McMurtry serving as Executive Chairman until 2018. The company is known for its long-term strategic outlook and significant investment in apprenticeship schemes and STEM education initiatives within the United Kingdom. In 2021, the founders placed their majority stake in the company up for sale, attracting interest from several international engineering firms, though the sale process was ultimately terminated. The company's governance and major strategic decisions are closely watched by investors on the London Stock Exchange and analysts from firms like JP Morgan Chase.

Financial performance

As a publicly listed company on the London Stock Exchange, Renishaw has historically demonstrated resilient financial performance, driven by its technological leadership and diversified industrial customer base. Its revenue is broadly split between its metrology and healthcare segments, with a significant portion generated from exports outside the United Kingdom, particularly in Asia and the Americas. Key financial metrics, including revenue, profit before tax, and earnings per share, are reported in its annual reports and are closely monitored by shareholders and financial institutions like HSBC. The company's financial strength allows for continued high investment in research and development, which is critical to maintaining its competitive edge against multinational rivals like Hexagon AB and Carl Zeiss AG.

Category:Companies listed on the London Stock Exchange Category:Engineering companies of the United Kingdom Category:Manufacturing companies of the United Kingdom Category:Companies based in Gloucestershire